Drugs / CN54ENV DNA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03663998 Comparator | Aug 2015 → May 2017 | HIV infectious disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CN54ENV DNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03663998 ↗ |
| Route | Intramuscular | “by in vivo electroporation using the Ichor Medical Systems TriGrid Delivery System for intramuscular (TDS-IM) or intradermal use (TDS-ID)” NCT03663998 ↗ |